Code
|
2601E
|
MA number
|
EU/1/18/1289/005
|
Product Form:
|
tbl flm 30x30 mg/120 mg/15 mg (fľ.HDPE)
|
MA Status:
|
E - Valid centralised marketing authorisation
|
Type of procedure:
|
EU
|
MAH, country:
|
Gilead Sciences Ireland UC , Ireland
|
Therapeutic Class:
|
42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK)
|
ATC:
|
J |
ANTIINFECTIVES FOR SYSTEMIC USE |
J05 |
ANTIVIRALS FOR SYSTEMIC USE |
J05A |
DIRECT ACTING ANTIVIRALS |
J05AR |
Antivirals for treatment of HIV infections, combinations |
J05AR20 |
Emtricitabine, tenofovir alafenamide and bictegravir |
|
Shelf life:
|
36 |
Route of admin.:
|
Oral use
|